Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.

被引:37
作者
Cryer, B [1 ]
机构
[1] Univ Texas, SW Med Sch, Dept Med, Gastroenterol Sect, Dallas, TX 75230 USA
[2] Dallas Vet Affairs Med Ctr, Dallas, TX USA
关键词
D O I
10.1056/NEJMe048330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:287 / 289
页数:3
相关论文
共 14 条
  • [1] ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)
    Braunwald, E
    Antman, EM
    Beasley, JW
    Califf, RM
    Cheitlin, MD
    Hochman, JS
    Jones, RH
    Kereiakes, D
    Kupersmith, J
    Levin, TN
    Pepine, CJ
    Schaeffer, JW
    Smith, EE
    Steward, DE
    Theroux, P
    Gibbons, RJ
    Alpert, JS
    Faxon, DP
    Fuster, V
    Gregoratos, G
    Hiratzka, LF
    Jacobs, AK
    Smith, SC
    [J]. CIRCULATION, 2002, 106 (14) : 1893 - 1900
  • [2] Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding
    Chan, FKL
    Ching, JYL
    Hung, LCT
    Wong, VWS
    Leung, VKS
    Kung, NNS
    Hui, AJ
    Wu, JCY
    Leung, WK
    Lee, VWY
    Lee, KKC
    Lee, YT
    Lau, JYW
    To, KF
    Chan, HLY
    Chung, SCS
    Sung, JJY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 238 - 244
  • [3] Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans
    Cryer, B
    Feldman, M
    [J]. GASTROENTEROLOGY, 1999, 117 (01) : 17 - 25
  • [4] Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
    Derry, S
    Loke, YK
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7270): : 1183 - +
  • [5] FORT FT, 2000, SCAND J GASTROENTERO, V35, P464
  • [6] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    Gent, M
    Beaumont, D
    Blanchard, J
    Bousser, MG
    Coffman, J
    Easton, JD
    Hampton, JR
    Harker, LA
    Janzon, L
    Kusmierek, JJE
    Panak, E
    Roberts, RS
    Shannon, JS
    Sicurella, J
    Tognoni, G
    Topol, EJ
    Verstraete, M
    Warlow, C
    [J]. LANCET, 1996, 348 (9038) : 1329 - 1339
  • [7] Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
    Kabbinavar, F
    Hurwitz, HI
    Fehrenbacher, L
    Meropol, NJ
    Novotny, WF
    Lieberman, G
    Griffing, S
    Bergsland, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 60 - 65
  • [8] Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use
    Lai, KC
    Lam, SK
    Chu, KM
    Wong, BCY
    Hui, WM
    Hu, WHC
    Lau, GKK
    Wong, WM
    Yuen, MF
    Chan, AOO
    Lai, CL
    Wong, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) : 2033 - 2038
  • [9] Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: A double-blind trial
    Laine, L
    Maller, ES
    Yu, C
    Quan, H
    Simon, T
    [J]. GASTROENTEROLOGY, 2004, 127 (02) : 395 - 402
  • [10] Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient
    Laine, L
    [J]. GASTROENTEROLOGY, 2001, 120 (03) : 594 - 606